Melanoma Research Foundation Breakthrough Consortium (MRFBC)

Go back to Experience
Coordinating Center
Emmes U.S.
Project Status
Active
Project Lifespan
02/28/2013 to 02/29/2016
Objective

The mission of the Melanoma Research Foundation Breakthrough Consortium (MRFBC) is to accelerate the research and development of the most promising therapeutics in melanoma in order to deliver curative options to patients.

Population

Patients with melanoma

Phase
II
Centers

•Dana Farber/Harvard Cancer Center
•Georgetown University
•H. Lee Moffitt Cancer Center
•M.D. Anderson Cancer Center
•Memorial-Sloan Kettering Cancer Center
•New York University
•Ohio State University
•The Angeles Clinic and Research Institute
•University of California, Los Angeles
•University of California, San Francisco
•University of Colorado
•University of Pennsylvania/Wistar Institute
•University of Pittsburgh
•University of Washington
•Vanderbilt University
•Yale University

Products
AdvantageEDC
GlobalTrace
Regulatory Tracking System
Services
Protocol Monitoring
Regulatory Affairs
Statistical Leadership and Project Management
Web-based Data Collection and Reporting Systems
Oncology